These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23494210)

  • 1. A useful EGFR-TK ligand for tumor diagnosis with SPECT: development of radioiodinated 6-(3-morpholinopropoxy)-7-ethoxy-4-(3'-iodophenoxy)quinazoline.
    Hirata M; Kanai Y; Naka S; Yoshimoto M; Kagawa S; Matsumuro K; Katsuma H; Yamaguchi H; Magata Y; Ohmomo Y
    Ann Nucl Med; 2013 Jun; 27(5):431-43. PubMed ID: 23494210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of radioiodinated phenoxyquinazoline and benzylaminoquinazoline derivatives as new EGF receptor tyrosine kinase imaging ligands for tumor diagnosis using SPECT.
    Hirata M; Kanai Y; Naka S; Matsumuro K; Kagawa S; Yoshimoto M; Ohmomo Y
    Ann Nucl Med; 2012 Jun; 26(5):381-9. PubMed ID: 22354330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of radioiodinated quinazoline derivative as a new ligand for EGF receptor tyrosine kinase activity using SPECT.
    Hirata M; Kanai Y; Naka S; Matsumuro K; Kagawa S; Yoshimoto M; Ohmomo Y
    Ann Nucl Med; 2011 Feb; 25(2):117-24. PubMed ID: 21058048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of gefitinib sensitivity with radioiodinated PHY based on EGFR expression.
    Yoshimoto M; Hirata M; Kanai Y; Naka S; Nishii R; Kagawa S; Kawai K; Ohmomo Y
    Biol Pharm Bull; 2014; 37(3):355-60. PubMed ID: 24583857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and preclinical evaluation of rhenium and technetium-99m "4 + 1" mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents.
    Kiritsis C; Shegani A; Makrypidi K; Roupa I; Lazopoulos A; Panagiotopoulou A; Triantopoulou S; Paravatou-Petsotas M; Pietzsch HJ; Pelecanou M; Papadopoulos M; Pirmettis I
    Bioorg Med Chem; 2022 Nov; 73():117012. PubMed ID: 36155319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents.
    Neto C; Fernandes C; Oliveira MC; Gano L; Mendes F; Kniess T; Santos I
    Nucl Med Biol; 2012 Feb; 39(2):247-60. PubMed ID: 22079040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of epidermal growth factor receptor status in glioblastomas.
    Zhu HJ; Ogawa M; Magata Y; Hirata M; Ohmomo Y; Namba H; Sakahara H
    Asia Ocean J Nucl Med Biol; 2013; 1(2):47-52. PubMed ID: 27408849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel radioiodinated anthranilate derivatives for in vivo imaging of vascular endothelial growth factor receptor with single-photon emission computed tomography.
    Hirata M; Asano A; Magata Y; Ohmomo Y; Temma T
    Ann Nucl Med; 2020 Jul; 34(7):486-495. PubMed ID: 32385783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of radioiodinated nucleoside analogs for imaging tissue proliferation: comparisons of six 5-iodonucleosides.
    Toyohara J; Hayashi A; Sato M; Gogami A; Tanaka H; Haraguchi K; Yoshimura Y; Kumamoto H; Yonekura Y; Fujibayashi Y
    Nucl Med Biol; 2003 Oct; 30(7):687-96. PubMed ID: 14499326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodination of new EGFR inhibitors as potential SPECT agents for molecular imaging of breast cancer.
    Fernandes C; Oliveira C; Gano L; Bourkoula A; Pirmettis I; Santos I
    Bioorg Med Chem; 2007 Jun; 15(12):3974-80. PubMed ID: 17449254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of EGFR-TK Expression with a
    Si Z; Hu P; Zhou J; Lin Q; Xiu Y; Cheng D
    Cancer Biother Radiopharm; 2019 Nov; 34(9):551-558. PubMed ID: 31436470
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.
    Bonasera TA; Ortu G; Rozen Y; Krais R; Freedman NM; Chisin R; Gazit A; Levitzki A; Mishani E
    Nucl Med Biol; 2001 May; 28(4):359-74. PubMed ID: 11395308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma.
    Sogawa C; Tsuji AB; Yoshida C; Inubushi M; Furukawa T; Koizumi M; Akahori Y; Ukai Y; Kurosawa G; Kurosawa Y; Saga T
    Nucl Med Commun; 2012 Jul; 33(7):719-25. PubMed ID: 22453549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
    Hoppmann S; Qi S; Miao Z; Liu H; Jiang H; Cutler CS; Bao A; Cheng Z
    J Biol Inorg Chem; 2012 Jun; 17(5):709-18. PubMed ID: 22418921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors.
    Abourbeh G; Dissoki S; Jacobson O; Litchi A; Ben Daniel R; Laki D; Levitzki A; Mishani E
    Nucl Med Biol; 2007 Jan; 34(1):55-70. PubMed ID: 17210462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.
    Su H; Seimbille Y; Ferl GZ; Bodenstein C; Fueger B; Kim KJ; Hsu YT; Dubinett SM; Phelps ME; Czernin J; Weber WA
    Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1089-99. PubMed ID: 18239919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of novel
    Chong Y; Chang J; Zhao W; He Y; Li Y; Zhang H; Qi C
    J Labelled Comp Radiopharm; 2018 Feb; 61(2):42-53. PubMed ID: 28833405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors.
    Mishani E; Abourbeh G; Rozen Y; Jacobson O; Laky D; Ben David I; Levitzki A; Shaul M
    Nucl Med Biol; 2004 May; 31(4):469-76. PubMed ID: 15093817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and evaluation of
    Liolios C; Shegani A; Roupa I; Kiritsis C; Makarem A; Paravatou-Petsotas M; Pelecanou M; Bouziotis P; Papadopoulos M; Kopka K; Pirmettis I
    Bioorg Chem; 2020 Jul; 100():103855. PubMed ID: 32428743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
    Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
    Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.